Re:Eloquis: Early in the market and targeted the wrong custo...
by ravitation on Friday January 26, 2018 @04:28PM
(#16243041)
My point was not so much about losing a battle over name recognition, that's something that happens relatively all the time. I mean specifically losing it, even to the general public that isn't on blood thinners (like myself), to a blood thinner. In a lot of developed countries, where direct to consumer pharmaceutical advertising isn't legal this obviously would not have happened...
[ Parent
| on HN ]
There are no comments on this comment yet.